For example, lubiprostone is an agonist of the chloride channel protein 2, which promotes the Cl− efflux out of intestinal cells into the lumen, for the management of functional constipation or constipation-predominant IBS (Camilleri et al., 2006; Andresen et al., 2007). This evidence concerns the gene CLCN2 and irritable bowel syndrome.